Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CYCN

Cyclerion Therapeutics Inc

May 12 • 12:28PM ET

3.13

-0.06 -1.92 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BIVI PRQR LCTX PALI BCDA

| Held by: ONEQ VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	30.84%	Shs Outstand	3.82M	Perf Week	-0.68%
Market Cap	13.54M	Forward P/E	-	EPS next Y	-0.99	Insider Trans	0.00%	Shs Float	3.00M	Perf Month	8.26%
Enterprise Value	10.30M	PEG	-	EPS next Q	-	Inst Own	19.51%	Short Float	1.89%	Perf Quarter	167.40%
Income	-3.53M	P/S	6.54	EPS this Y	10.45%	Inst Trans	1.70%	Short Ratio	0.01	Perf Half Y	92.89%
Sales	2.07M	P/B	1.32	EPS next Y	17.50%	ROA	-36.07%	Short Interest	0.06M	Perf YTD	146.35%
Book/sh	2.38	P/C	4.18	EPS next 5Y	-	ROE	-39.34%	52W High	8.48 -63.11%	Perf Year	-3.44%
Cash/sh	0.75	P/FCF	-	EPS past 3/5Y	62.04% 53.53%	ROIC	-38.83%	52W Low	1.03 204.75%	Perf 3Y	-29.91%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	91.14% -2.01%	Gross Margin	-	Volatility	4.01% 7.06%	Perf 5Y	-94.70%
Dividend TTM	-	EV/Sales	4.98	EPS Y/Y TTM	3.82%	Oper. Margin	-239.78%	ATR (14)	0.31	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.15	Sales Y/Y TTM	3.70%	Profit Margin	-170.11%	RSI (14)	53.12	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.15	EPS Q/Q	-200.43%	SMA20	0.83%	Beta	1.82	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-43.24%	SMA50	21.72%	Rel Volume	0.01	Prev Close	3.19
Employees	1	LT Debt/Eq	0.00	Earnings	Mar 25	SMA200	51.16%	Avg Volume	4.72M	Price	3.13
IPO	Mar 18, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	17,586	Change	-1.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)